Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

1.

Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease.

Kedmi M, Bar-Shira A, Gurevich T, Giladi N, Orr-Urtreger A.

Mol Neurodegener. 2011 Sep 23;6:66. doi: 10.1186/1750-1326-6-66.

PMID:
21943286
[PubMed]
Free PMC Article
2.

The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?

Orr-Urtreger A, Shifrin C, Rozovski U, Rosner S, Bercovich D, Gurevich T, Yagev-More H, Bar-Shira A, Giladi N.

Neurology. 2007 Oct 16;69(16):1595-602.

PMID:
17938369
[PubMed - indexed for MEDLINE]
3.

LRRK2 mutations in Parkinson's disease: confirmation of a gender effect in the Italian population.

Cilia R, Siri C, Rusconi D, Allegra R, Ghiglietti A, Sacilotto G, Zini M, Zecchinelli AL, Asselta R, Duga S, Paganoni AM, Pezzoli G, Seia M, Goldwurm S.

Parkinsonism Relat Disord. 2014 Aug;20(8):911-4. doi: 10.1016/j.parkreldis.2014.04.016. Epub 2014 Apr 25.

PMID:
24816003
[PubMed - in process]
Free PMC Article
4.

Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease.

Gan-Or Z, Bar-Shira A, Gurevich T, Giladi N, Orr-Urtreger A.

Neurogenetics. 2011 Nov;12(4):325-32. doi: 10.1007/s10048-011-0293-6. Epub 2011 Aug 12.

PMID:
21837367
[PubMed - indexed for MEDLINE]
5.

β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.

Moraitou M, Hadjigeorgiou G, Monopolis I, Dardiotis E, Bozi M, Vassilatis D, Vilageliu L, Grinberg D, Xiromerisiou G, Stefanis L, Michelakakis H.

Mol Genet Metab. 2011 Sep-Oct;104(1-2):149-52. doi: 10.1016/j.ymgme.2011.06.015. Epub 2011 Jun 24.

PMID:
21745757
[PubMed - indexed for MEDLINE]
6.

Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease.

Botta-Orfila T, Tolosa E, Gelpi E, Sànchez-Pla A, Martí MJ, Valldeoriola F, Fernández M, Carmona F, Ezquerra M.

Neurobiol Dis. 2012 Jan;45(1):462-8. doi: 10.1016/j.nbd.2011.08.033. Epub 2011 Sep 16.

PMID:
21946334
[PubMed - indexed for MEDLINE]
7.

Altered expression of autophagic genes in the peripheral leukocytes of patients with sporadic Parkinson's disease.

Wu G, Wang X, Feng X, Zhang A, Li J, Gu K, Huang J, Pang S, Dong H, Gao H, Yan B.

Brain Res. 2011 Jun 7;1394:105-11. doi: 10.1016/j.brainres.2011.04.013. Epub 2011 Apr 13.

PMID:
21514572
[PubMed - indexed for MEDLINE]
8.

Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.

Gan-Or Z, Giladi N, Rozovski U, Shifrin C, Rosner S, Gurevich T, Bar-Shira A, Orr-Urtreger A.

Neurology. 2008 Jun 10;70(24):2277-83. doi: 10.1212/01.wnl.0000304039.11891.29. Epub 2008 Apr 23.

PMID:
18434642
[PubMed - indexed for MEDLINE]
9.

Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's disease.

Giladi N, Mirelman A, Thaler A, Bar-Shira A, Gurevich T, Orr-Urtreger A.

J Neurol Sci. 2011 Nov 15;310(1-2):17-20. doi: 10.1016/j.jns.2011.06.005. Epub 2011 Jun 25.

PMID:
21704337
[PubMed - indexed for MEDLINE]
10.

The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.

Thaler A, Ash E, Gan-Or Z, Orr-Urtreger A, Giladi N.

J Neural Transm. 2009 Nov;116(11):1473-82. doi: 10.1007/s00702-009-0303-0. Review.

PMID:
19756366
[PubMed - indexed for MEDLINE]
11.

LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease.

Gan-Or Z, Bar-Shira A, Mirelman A, Gurevich T, Kedmi M, Giladi N, Orr-Urtreger A.

Neurogenetics. 2010 Feb;11(1):121-5. doi: 10.1007/s10048-009-0198-9. Epub 2009 May 21.

PMID:
19458969
[PubMed - indexed for MEDLINE]
12.

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel.

Hassin-Baer S, Laitman Y, Azizi E, Molchadski I, Galore-Haskel G, Barak F, Cohen OS, Friedman E.

J Neurol. 2009 Mar;256(3):483-7. doi: 10.1007/s00415-009-0117-x. Epub 2009 Mar 24.

PMID:
19412725
[PubMed - indexed for MEDLINE]
13.

Exon arrays reveal alternative splicing aberrations in Parkinson's disease leukocytes.

Soreq L, Bergman H, Israel Z, Soreq H.

Neurodegener Dis. 2012;10(1-4):203-6. doi: 10.1159/000332598. Epub 2011 Dec 9.

PMID:
22156489
[PubMed - indexed for MEDLINE]
Free Article
14.

Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.

Bar-Shira A, Hutter CM, Giladi N, Zabetian CP, Orr-Urtreger A.

Neurogenetics. 2009 Oct;10(4):355-8. doi: 10.1007/s10048-009-0186-0. Epub 2009 Mar 13.

PMID:
19283415
[PubMed - indexed for MEDLINE]
15.

Differential expression of splice variant and wild-type parkin in sporadic Parkinson's disease.

Tan EK, Shen H, Tan JM, Lim KL, Fook-Chong S, Hu WP, Paterson MC, Chandran VR, Yew K, Tan C, Yuen Y, Pavanni R, Wong MC, Puvan K, Zhao Y.

Neurogenetics. 2005 Dec;6(4):179-84. Epub 2005 Aug 6.

PMID:
16086186
[PubMed - indexed for MEDLINE]
16.

Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease.

Lesage S, Anheim M, Condroyer C, Pollak P, Durif F, Dupuits C, Viallet F, Lohmann E, Corvol JC, Honoré A, Rivaud S, Vidailhet M, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group.

Hum Mol Genet. 2011 Jan 1;20(1):202-10. doi: 10.1093/hmg/ddq454. Epub 2010 Oct 14.

PMID:
20947659
[PubMed - indexed for MEDLINE]
Free Article
17.

Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease.

Kay DM, Bird TD, Zabetian CP, Factor SA, Samii A, Higgins DS, Nutt J, Roberts JW, Griffith A, Leis BC, Montimurro JS, Philpott S, Payami H.

Genet Test. 2006 Fall;10(3):221-7.

PMID:
17020475
[PubMed - indexed for MEDLINE]
18.

MAPK-pathway activity, Lrrk2 G2019S, and Parkinson's disease.

White LR, Toft M, Kvam SN, Farrer MJ, Aasly JO.

J Neurosci Res. 2007 May 1;85(6):1288-94.

PMID:
17385669
[PubMed - indexed for MEDLINE]
19.

LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study.

Sharma S, Bandopadhyay R, Lashley T, Renton AE, Kingsbury AE, Kumaran R, Kallis C, Vilariño-Güell C, O'Sullivan SS, Lees AJ, Revesz T, Wood NW, Holton JL.

Neuropathol Appl Neurobiol. 2011 Dec;37(7):777-90. doi: 10.1111/j.1365-2990.2011.01187.x.

PMID:
21696411
[PubMed - indexed for MEDLINE]
20.

Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements.

Scarciolla O, Brancati F, Valente EM, Ferraris A, De Angelis MV, Valbonesi S, Garavaglia B, Uncini A, Palka G, Stuppia L, Dallapiccola B.

Mov Disord. 2007 Nov 15;22(15):2274-8.

PMID:
17914726
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk